C12Y 305/03003
Creatinase , i.e. creatine amidinohydrolase
Official title: Creatinase (3.5.3.3), i.e. creatine amidinohydrolase
C12Y305/03003 (Creatinase , i.e. creatine amidinohydrolase) appears on 5 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 4
- Assignees
- 4
- Inventors
- 10
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 2 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Analyte sensors and sensing methods for detecting creatinine28 Jul 2026US 12,693,255 B2Abbott Diabetes Care Inc.
- Method for correcting Crea sensor for calcium inhibition6 Apr 2021US 10,969,358 B2Radiometer Medical ApS
- Diagnostic devices with modifiable hydrophobic surfaces22 Oct 2019US 10,449,536 B2Siemens Healthcare Diagnostics Inc.
- Thermostable creatine amidinohydrolase and process for producing the same23 Nov 2004US 6,821,766 B1Kikkoman Corporation
- Creatine amidinohydrolase and process for producing the same2 Mar 2004US 6,699,700 B1Kikkoman Corporation
- Analyte sensors and sensing methods for detecting creatinine8 Oct 2026US 2026/0309669 A1Abbott Diabetes Care Inc.
- Analyte Sensors and Sensing Methods for Detecting Creatinine30 Jul 2020US 2020/0241015 A1Abbott Diabetes Care Inc.
- Method for correcting crea sensor for calcium inhibition19 Jul 2018US 2018/0202963 A1Radiometer Medical ApS
- Diagnostic devices with modifiable hydrophobic surfaces31 Aug 2017US 2017/0246627 A1Siemens Healthcare Diagnostics Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.